XML 66 R55.htm IDEA: XBRL DOCUMENT v3.4.0.3
COMMITMENTS AND CONTINGENCIES (Details)
3 Months Ended 6 Months Ended 12 Months Ended 13 Months Ended 15 Months Ended 23 Months Ended 48 Months Ended 60 Months Ended
Dec. 24, 2015
EUR (€)
€ / shares
shares
Mar. 31, 2016
USD ($)
shares
Mar. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
shares
Mar. 16, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Mar. 31, 2014
USD ($)
May. 13, 2016
USD ($)
Feb. 22, 2013
USD ($)
Jan. 31, 2015
USD ($)
Mar. 31, 2011
USD ($)
Dec. 24, 2015
$ / shares
Dec. 24, 2015
EUR (€)
shares
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Mar. 07, 2008
USD ($)
Future minimum lease payments [Abstract]                                    
2016 (Nine months)   $ 89,880                                
2017   119,840                                
2018   28,858                                
2019   0                                
2020   0                                
Total   238,578                                
Rent expense for operating lease   29,960 $ 31,165                              
Related Party Obligations [Abstract]                                    
Outstanding accounts receivable   $ 0     $ 2,805                          
Concentration risk, percentage   100.00% 100.00%                              
License purchase and termination agreement [Abstract]                                    
Issuance of common stock (in shares) | shares   62,974,431     36,834,933                          
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation liability   $ 42,282     $ 383,564   $ 150,000 $ 150,000               $ 150,000 $ 150,000  
Deferred compensation   575,846     533,564                          
Compensation accrued liabilities   302,263     259,981                          
Compensation accounts payable   273,583     273,583                          
Milestone payments [Line Items]                                    
Future milestone obligations   4,750,000                                
Kerry P. Gray [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation liability [1],[2],[3]   0     275,153   150,000 150,000               150,000 150,000  
Deferred compensation [1],[2],[3]   425,153                                
Repayment of temporarily deferred compensation             269,986 312,500                    
Proceeds from issuance of common stock under March 2013 offering             100,000 300,000                    
Temporary advance of working capital         37,300                          
Kerry P. Gray [Member] | Temporarily Deferred Compensation [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation         275,153   150,000 582,486                    
Kerry P. Gray [Member] | President [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation         51,770   62,500                      
Kerry P. Gray [Member] | Board of Directors Chairman [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation         186,083   87,500                      
Terrance K. Wallberg [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation liability   25,897     53,540   0 0               0 0  
Deferred compensation   79,437                                
Other Employees [Member]                                    
Summary of compensation earned, compensation paid in cash, and compensation temporarily deferred [Abstract]                                    
Deferred compensation liability   16,385     54,871   $ 0 $ 0               $ 0 $ 0  
Deferred compensation   71,256                                
Altrazeal Trading GmbH [Member] | Licensing Agreements [Member]                                    
License purchase and termination agreement [Abstract]                                    
Percentage of ownership interest                             25.00%      
Transfer fee | € € 1,570,271                                  
Issuance of common stock (in shares) | shares                             4,441,606      
Aggregate shares of common stock issued upon exercise of warrants (in shares) | shares                             444,161      
Warrants exercise price (in dollars per share) | $ / shares                           $ 0.68        
Term of warrants 1 year                                  
Deduction in inventory payment (in dollars per share) | € / shares € 4.20                                  
Number of days closing a registration statement 20 days                                  
Common stock reissued (in shares) | shares 2,500,000                                  
Altrazeal Trading GmbH [Member] | Licensing Agreements [Member] | Maximum [Member]                                    
License purchase and termination agreement [Abstract]                                    
Inventory payments | €                             € 88,834      
Altrazeal Distributors [Member] | Revenue [Member]                                    
Related Party Obligations [Abstract]                                    
Related party sales   $ 0 $ 282,000                              
Concentration risk, percentage   0.00% 96.00%                              
Altrazeal Distributors [Member] | Accounts Receivable [Member]                                    
Related Party Obligations [Abstract]                                    
Outstanding accounts receivable   $ 0     $ 3,000                          
Concentration risk, percentage   0.00%     3.00%                          
IPMD GmbH [Member] | Licensing Agreements [Member]                                    
License purchase and termination agreement [Abstract]                                    
Transfer fee | € € 703,500                                  
Issuance of common stock (in shares) | shares                             2,095,241      
Aggregate shares of common stock issued upon exercise of warrants (in shares) | shares                             209,525      
Warrants exercise price (in dollars per share) | $ / shares                           $ 0.68        
Term of warrants 1 year                                  
Office and Laboratory Space [Member]                                    
Operating Leased Assets [Line Items]                                    
Minimum monthly lease obligation       $ 9,436   $ 9,379     $ 9,193   $ 9,776   $ 9,330          
Office Equipment [Member]                                    
Operating Leased Assets [Line Items]                                    
Minimum monthly lease obligation                       $ 744            
Office Equipment [Member] | Subsequent Event [Member]                                    
Operating Leased Assets [Line Items]                                    
Minimum monthly lease obligation                   $ 551                
Access Pharmaceuticals [Member] | Annual Sales, Certain Products [Member] | Minimum [Member]                                    
Milestone payments [Line Items]                                    
Milestone for payment   $ 20,000,000                                
Access Pharmaceuticals [Member] | Annual Sales, Certain Products [Member] | Maximum [Member]                                    
Milestone payments [Line Items]                                    
Milestone for payment   40,000,000                                
Access Pharmaceuticals [Member] | Annual Sales, Any One Certain Product [Member]                                    
Milestone payments [Line Items]                                    
Milestone for payment   20,000,000                                
Access Pharmaceuticals [Member] | Cumulative Sales, Certain Products [Member] | Minimum [Member]                                    
Milestone payments [Line Items]                                    
Milestone for payment   50,000,000                                
Access Pharmaceuticals [Member] | Cumulative Sales, Certain Products [Member] | Maximum [Member]                                    
Milestone payments [Line Items]                                    
Milestone for payment   $ 100,000,000                                
ProStrakan Ltd [Member]                                    
Milestone payments [Line Items]                                    
Royalty percentage   30.00%                               30.00%
ProStrakan Ltd [Member] | Maximum [Member]                                    
Milestone payments [Line Items]                                    
Future milestone obligations   $ 1,400,000                               $ 1,400,000
[1] During 2014, Mr. Gray temporarily deferred compensation of $150,000 which consisted of $62,500 earned as salary compensation for his duties as President of the Company and $87,500 for his duties as Chairman of the Executive Committee of the Company's Board of Directors. During 2014, Mr. Gray was also repaid $269,986 of temporarily deferred compensation, of which $100,000 was used by Mr. Gray for funding required pursuant to a Securities Purchase Agreement, dated March 14, 2013 (the "March 2013 Offering"). Prior to 2014, over a three year period Mr. Gray temporarily deferred, at various times, aggregate compensation of $582,486 and during the same time period was also repaid $312,500 of temporarily deferred compensation, of which $300,000 was used by Mr. Gray for funding required pursuant to the March 2013 Offering.
[2] During 2015, Mr. Gray temporarily deferred compensation of $275,153 which consisted of $51,770 earned as salary compensation for his duties as President of the Company, $186,083 for his duties as Chairman of the Executive Committee of the Company's Board of Directors, and $37,300 as a temporary advance of working capital.
[3] On November 19, 2015, Mr. Gray resigned as the Company's President and Chief Executive Officer and on February 18, 2016 resigned as a director for the Company.